Avar Ls Topical Suspension, Cleanser 10-2pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

AVAR LS: Topical suspension, cleanser (10-2%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
AVAR LS 10%-2% Cleanser

CVS Pharmacy Patient Statistics for AVAR LS: Topical suspension, cleanser(10-2%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

AVAR LS 10%-2% Topical Cleanser

NDC: 001780475
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Acne Vulgaris, Acne Rosacea, Seborrheic Dermatitis

Storage Information
Protect from freezing
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Avoid excessive heat (above 104 degrees F)
AVAR LS 10%-2% Topical Cleanser

Reported Side Effects for AVAR LS 10%-2% Topical Cleanser

Allergic Skin Reaction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Photosensitivity Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Bruises Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Skin Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with AVAR LS

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5